Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment

Franko, 2012, Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841, J Clin Oncol, 30, 263, 10.1200/JCO.2011.37.1039 Sugarbaker, 1995, Peritonectomy procedures, Ann Surg, 221, 29, 10.1097/00000658-199501000-00004 Cao, 2009, A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin, Ann Surg Oncol, 16, 2152, 10.1245/s10434-009-0487-4 Elias, 2009, Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin, J Clin Oncol, 27, 681, 10.1200/JCO.2008.19.7160 Klaver, 2012, Peritoneal carcinomatosis of colorectal origin: incidence, prognosis and treatment options, World J Gastroenterol, 18, 5489, 10.3748/wjg.v18.i39.5489 Yan, 2007, Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy, Ann Surg Oncol, 14, 1807, 10.1245/s10434-007-9350-7 Glehen, 2010, Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients, Cancer, 116, 5608, 10.1002/cncr.25356 Konigsrainer, 2012, Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, World J Gastroenterol, 18, 2061, 10.3748/wjg.v18.i17.2061 Hagendoorn, 2009, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival, Eur J Surg Oncol, 35, 833, 10.1016/j.ejso.2008.10.006 Verwaal, 2004, Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy, Br J Surg, 91, 739, 10.1002/bjs.4516 Dindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097/01.sla.0000133083.54934.ae Lemmens, 2011, Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study, Int J Cancer, 128, 2717, 10.1002/ijc.25596 Segelman, 2012, Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer, Br J Surg, 99, 699, 10.1002/bjs.8679 Obrand, 1997, Incidence and patterns of recurrence following curative resection for colorectal carcinoma, Dis Colon Rectum, 40, 15, 10.1007/BF02055676 van der Bij, 2009, The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer, Ann Surg, 249, 727, 10.1097/SLA.0b013e3181a3ddbd Konigsrainer, 2009, Local peritonectomy highly attracts free floating intraperitoneal colorectal tumour cells in a rat model, Cell Physiol Biochem, 23, 371, 10.1159/000218183 da Silva, 2006, Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer, J Am Coll Surg, 203, 878, 10.1016/j.jamcollsurg.2006.08.024